What Has Been the Growth of the Platelet Rich Plasma Market So Far?
The platelet rich plasma market has seen considerable growth due to a variety of factors.
• The platelet rich plasma market has shown rapid growth in recent years. It is expected to rise from $0.71 billion in 2024 to $0.83 billion in 2025, with a compound annual growth rate (CAGR) of 17.4%.
This growth is driven by rising demand for minimally invasive procedures, chronic conditions like arthritis, pain management, and increasing adoption in veterinary medicine.
What Is the Forecasted Market Size and Growth Rate for The Platelet Rich Plasma Market Size In The Coming Years?
The platelet rich plasma market is expected to maintain its strong growth trajectory in upcoming years.
• The platelet rich plasma market is projected to reach $1.57 billion by 2029, with a CAGR of 17.2%.
The growth is attributed to sports injuries, orthopedic disorders, aesthetic procedure demand, aging-related conditions, and clinical trial support. Trends include advancements in processing systems, new PRP applications, ongoing research, and increased investment in the field.
What Factors Are Driving Growth In The Platelet Rich Plasma Market?
The growth of the platelet-rich plasma market is anticipated to be fueled by the increasing occurrence of sports injuries. The escalation in sports-related injuries can be attributed to greater involvement in sports, a surge in participation in youth sports initiatives, age-related elements, as well as insufficient coaching and supervision. Platelet-rich plasma (PRP) therapy plays an instrumental role in athletic injury recuperation by enhancing tissue repair and regeneration, decreasing inflammation, and improving the healing of tendons and ligaments. This presents athletes with a less invasive treatment alternative coupled with potentially quicker recovery spans. For instance, the Howden Group Holdings Ltd, a UK insurance intermediary firm, reported in November 2023 that injuries logged in October 2022 had sidelined players for an average of 11.35 days pre-tournament. However, post-tournament in January 2023, this escalated to 19.41 days. The report highlighted a significant surge during this period in injuries to the ankle, calf/shin, and hamstring, with increases of 170%, 200%, and 130%, respectively. Consequently, the mounting prevalence of sports injuries is stimulating the expansion of the platelet-rich plasma market.
What Are The Main Segments Of The Global Platelet Rich Plasma Market?
The platelet rich plasma market covered in this report is segmented –
1) By Type: Pure Platelet Rich Plasma, Leukocyte-Rich Platelet Rich Plasma, Leukocyte-Rich Fibrin, Other Types
2) By Origin: Allogeneic Platelet Rich Plasma, Autologous Platelet Rich Plasma, Homologous Platelet Rich Plasma
3) By Application: Cosmetic Surgery And Aesthetics, General Surgery, Neurosurgery, Orthopedic And Spinal Surgery, Other Applications
4) By End User: Hospitals And Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Pure Platelet Rich Plasma: Low Concentration PRP, High Concentration PRP
2) By Leukocyte-Rich Platelet Rich Plasma: Autologous LR-PRP, Allogeneic LR-PRP
3) By Leukocyte-Rich Fibrin: Injectable Leukocyte-Rich Fibrin, Membrane Leukocyte-Rich Fibrin
4) By Other Types: Platelet Rich Fibrin (PRF), Concentrated Platelet-Rich Plasma (cPRP), Platelet-Poor Plasma (PPP)
Pre-Book The Platelet Rich Plasma Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Platelet Rich Plasma Market?
Prominent organisations in the platelet-rich plasma market are advancing their operations by producing ready-to-use plasma products. These offer superior quality and great value in order to cater to the growing consumer demand for platelet-rich plasma treatments within the aesthetics industry. Pre-prepared platelet-rich plasma products provide an easily accessible therapeutic resource, ensuring a consistent dosage and strength without the need for individualised manufacture. An example of this was in July 2023, when 4T Medical, a cosmeceutical and medical aesthetic product enterprise based in the UK, revealed their new label platelet-rich plasma kit. Designed to create autologous PRP, this CE 2195-registered medical apparatus effectively aids in skin rejuvenation and healing. The kit is inclusive of two 10-ml test tubes filled with sodium citrate anticoagulant and all required items for drawing blood. Post the centrifugation process, the PRP can be easily identified and administered to improve healing, catalyse collagen production, firm the skin, and spur hair growth.
Who Are the Key Players In The Platelet Rich Plasma Market?
Major companies operating in the platelet rich plasma market are:
• Johnson & Johnson Services Inc.
• Stryker
• Zimmer Biomet
• Terumo Corporation
• Arthrex Inc.
• Pall Corporation
• Globus Medical
• LifeNet Health
• Exactech Inc.
• BioBridge Global
• Regen Lab SA
• Celling Biosciences Inc.
• Eclipse Aesthetics LLC
• Regenexx
• Isto Biologics
• Royal Biologics
• Apex Biologix
• EmCyte Corporation
• Medira Ltd.
• Nuo Therapeutics Inc.
• Juventix Regenerative Medical LLC.
• Estar Medical
• Dr PRP USA LLC
• MDBiologix
• Vivostat A/S
What Is The Most Dominant Region In The Platelet Rich Plasma Market?
North America was the largest region in the platelet-rich plasma market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet rich plasma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
